IHI vs PSCH

Key Takeaways

• IHI provides concentrated exposure to large-cap U.S. medical device manufacturers, tracking the Dow Jones U.S. Select Medical Equipment Index with 47 holdings and an expense ratio of 0.38%.
• PSCH offers broader small-cap healthcare exposure across biotech, providers, and equipment via the S&P SmallCap 600 Capped Health Care Index, holding around 77 stocks at a lower 0.29% expense ratio.
• IHI's top holdings like ISRG and ABT dominate (over 70% of assets), contrasting PSCH's more balanced top 10 at about 34%.
• Both ETFs are passive and non-diversified in healthcare (nearly 100% sector allocation), but PSCH carries higher volatility from small-cap focus.
• IHI suits investors targeting established medical device innovation; PSCH appeals for small-cap growth potential in diverse healthcare subsectors.
• Cost efficiency favors PSCH, while IHI benefits from greater liquidity and scale (AUM over $3 billion vs. PSCH's ~$130 million).

Introduction

Comparing IHI and PSCH highlights key trade-offs in healthcare ETF investing. Both target the resilient U.S. healthcare sector but differ in market cap and sub-focus: IHI zeros in on medical devices, while PSCH spans small-cap healthcare firms. Amid sector rotation toward defensives, aging demographics boosting demand for devices and services, and innovation in biotech, these ETFs offer alternative paths to healthcare exposure. Investors weigh IHI's stability from blue-chip device makers against PSCH's growth tilt via nimble small caps, especially as broader market cycles favor value and quality over speculative tech.

iShares U.S. Medical Devices ETF (IHI) Overview

The iShares U.S. Medical Devices ETF (IHI) is a passive fund seeking to track the Dow Jones U.S. Select Medical Equipment Index, comprising U.S. equities manufacturing and distributing non-disposable medical devices like imaging scanners, pacemakers, and prosthetics. Launched in 2006, it holds 47 stocks, emphasizing large-cap leaders. Top holdings include ISRG (Intuitive Surgical, ~16.7%), ABT (Abbott Laboratories, ~15.7%), SYK (Stryker, ~10.5%), EW (Edwards Lifesciences, ~5%), and IDXX (IDEXX Laboratories, ~4.5%), accounting for over 70% of assets in a market-cap-weighted approach.

Nearly 100% allocated to healthcare equipment, its expense ratio is 0.38%. The fund rebalances quarterly to align with the index, maintaining low turnover (~16%). With strong liquidity on NYSE Arca, IHI provides targeted access to device innovation without broader healthcare dilution.

Invesco S&P SmallCap Health Care ETF (PSCH) Overview

The Invesco S&P SmallCap Health Care ETF (PSCH) passively tracks the S&P SmallCap 600 Capped Health Care Index, measuring small-capitalization U.S. healthcare firms per Global Industry Classification Standard (GICS). Inception in 2010, it features ~77 holdings for diversified small-cap exposure. Top holdings: MOH (Molina Healthcare, ~5.3%), GKOS (Glaukos, ~4.5%), KRYS (Krystal Biotech, ~4%), BTSG (BrightSpring Health Services, ~3.8%), and TFX (Teleflex, ~3.1%), with top 10 at ~34%.

Sector breakdown: biotechnology (~28%), health care equipment (~25%), providers/services (~24%), pharmaceuticals (~19%). Expense ratio of 0.29% enhances cost efficiency. Capped weighting curbs concentration; rebalanced per index methodology. Trading on Nasdaq, PSCH targets small-cap growth across healthcare subsectors.

Industry and Thematic Backdrop

The healthcare sector, bolstered by aging populations and chronic disease prevalence, faces a dynamic environment. Medical devices benefit from procedural volumes, robotic surgery advances, and remote monitoring amid value-based care shifts. Small-cap healthcare rides biotech innovation, M&A (mergers and acquisitions) waves, and regulatory tailwinds like streamlined approvals, though sensitive to funding cycles. Macro drivers include moderating interest rates aiding growth stocks, policy uncertainties on drug pricing, and AI integration in diagnostics. Capital flows favor defensives as tech cools; sector risks encompass reimbursement pressures and supply chain issues. Both ETFs position for demographic tailwinds, with devices offering stability and small caps upside from innovation.

Performance and Positioning Comparison

In recent market cycles, IHI has shown relative stability, buoyed by large-cap device leaders' earnings resilience and innovation pipelines, amid sector rotations from growth to quality. PSCH, with small-cap beta, exhibits higher volatility but potential outperformance during risk-on phases or biotech rallies. Over recent months, healthcare lagged broader indices, yet IHI's concentration in established names like ISRG provided downside protection versus PSCH's exposure to cyclical providers and early-stage biotechs. Volatility differences stem from IHI's lower beta (~0.94) versus PSCH's (~1.06), tied to macro shifts like rate expectations favoring large caps and commodity trends impacting small-cap funding.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening, empowering data-driven decisions across asset classes. Explore it today to uncover healthcare ETF insights and beyond.

Tickeron AI Verdict

Tickeron’s AI currently favors IHI for its superior structural strength, liquidity, and trend consistency in medical devices amid defensive rotations. While PSCH offers cost efficiency and small-cap diversification, IHI's large-cap focus, lower relative volatility, and momentum in established innovators provide a higher probability of outperformance in the prevailing environment of sector recovery and quality bias (~65% edge based on observable factors).

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations